Cargando…

Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis

Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chang-Youh, Li, Ko-Jen, Shen, Chieh-Yu, Lu, Cheng-Hsun, Lee, Hui-Ting, Wu, Tsai-Hung, Ng, Yee-Yung, Tsao, Yen-Po, Hsieh, Song-Chou, Yu, Chia-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298725/
https://www.ncbi.nlm.nih.gov/pubmed/37373215
http://dx.doi.org/10.3390/ijms241210066
_version_ 1785064189190995968
author Tsai, Chang-Youh
Li, Ko-Jen
Shen, Chieh-Yu
Lu, Cheng-Hsun
Lee, Hui-Ting
Wu, Tsai-Hung
Ng, Yee-Yung
Tsao, Yen-Po
Hsieh, Song-Chou
Yu, Chia-Li
author_facet Tsai, Chang-Youh
Li, Ko-Jen
Shen, Chieh-Yu
Lu, Cheng-Hsun
Lee, Hui-Ting
Wu, Tsai-Hung
Ng, Yee-Yung
Tsao, Yen-Po
Hsieh, Song-Chou
Yu, Chia-Li
author_sort Tsai, Chang-Youh
collection PubMed
description Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of glomeruli to cause inflammation. The activated complements in the IC act as chemoattractants to chemically attract both innate and adaptive immune cells to the kidney tissues, causing inflammatory reactions. However, recent investigations have unveiled that not only the infiltrating immune-related cells, but resident kidney cells, including glomerular mesangial cells, podocytes, macrophage-like cells, tubular epithelial cells and endothelial cells, may also actively participate in the inflammatory and immunological reactions in the kidney. Furthermore, the adaptive immune cells that are infiltrated are genetically restricted to autoimmune predilection. The autoantibodies commonly found in SLE, including anti-dsDNA, are cross-reacting with not only a broad spectrum of chromatin substances, but also extracellular matrix components, including α-actinin, annexin II, laminin, collagen III and IV, and heparan sulfate proteoglycan. Besides, the glycosylation on the Fab portion of IgG anti-dsDNA antibodies can also affect the pathogenic properties of the autoantibodies in that α-2,6-sialylation alleviates, whereas fucosylation aggravates their nephritogenic activity. Some of the coexisting autoantibodies, including anti-cardiolipin, anti-C1q, anti-ribosomal P autoantibodies, may also enhance the pathogenic role of anti-dsDNA antibodies. In clinical practice, the identification of useful biomarkers for diagnosing, monitoring, and following up on LN is quite important for its treatments. The development of a more specific therapeutic strategy to target the pathogenic factors of LN is also critical. We will discuss these issues in detail in the present article.
format Online
Article
Text
id pubmed-10298725
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102987252023-06-28 Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis Tsai, Chang-Youh Li, Ko-Jen Shen, Chieh-Yu Lu, Cheng-Hsun Lee, Hui-Ting Wu, Tsai-Hung Ng, Yee-Yung Tsao, Yen-Po Hsieh, Song-Chou Yu, Chia-Li Int J Mol Sci Review Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of glomeruli to cause inflammation. The activated complements in the IC act as chemoattractants to chemically attract both innate and adaptive immune cells to the kidney tissues, causing inflammatory reactions. However, recent investigations have unveiled that not only the infiltrating immune-related cells, but resident kidney cells, including glomerular mesangial cells, podocytes, macrophage-like cells, tubular epithelial cells and endothelial cells, may also actively participate in the inflammatory and immunological reactions in the kidney. Furthermore, the adaptive immune cells that are infiltrated are genetically restricted to autoimmune predilection. The autoantibodies commonly found in SLE, including anti-dsDNA, are cross-reacting with not only a broad spectrum of chromatin substances, but also extracellular matrix components, including α-actinin, annexin II, laminin, collagen III and IV, and heparan sulfate proteoglycan. Besides, the glycosylation on the Fab portion of IgG anti-dsDNA antibodies can also affect the pathogenic properties of the autoantibodies in that α-2,6-sialylation alleviates, whereas fucosylation aggravates their nephritogenic activity. Some of the coexisting autoantibodies, including anti-cardiolipin, anti-C1q, anti-ribosomal P autoantibodies, may also enhance the pathogenic role of anti-dsDNA antibodies. In clinical practice, the identification of useful biomarkers for diagnosing, monitoring, and following up on LN is quite important for its treatments. The development of a more specific therapeutic strategy to target the pathogenic factors of LN is also critical. We will discuss these issues in detail in the present article. MDPI 2023-06-13 /pmc/articles/PMC10298725/ /pubmed/37373215 http://dx.doi.org/10.3390/ijms241210066 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tsai, Chang-Youh
Li, Ko-Jen
Shen, Chieh-Yu
Lu, Cheng-Hsun
Lee, Hui-Ting
Wu, Tsai-Hung
Ng, Yee-Yung
Tsao, Yen-Po
Hsieh, Song-Chou
Yu, Chia-Li
Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title_full Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title_fullStr Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title_full_unstemmed Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title_short Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
title_sort decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298725/
https://www.ncbi.nlm.nih.gov/pubmed/37373215
http://dx.doi.org/10.3390/ijms241210066
work_keys_str_mv AT tsaichangyouh deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT likojen deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT shenchiehyu deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT luchenghsun deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT leehuiting deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT wutsaihung deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT ngyeeyung deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT tsaoyenpo deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT hsiehsongchou deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis
AT yuchiali deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis